Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Five Healthcare Stocks To Diversify Your Portfolio
Nov 18, 2008 10:19 AM
- Generics Giant Teva Shines
Nov 09, 2008 01:53 PM
- Teva Beats On Profits: A Biogeneric Boon In '09?
Nov 06, 2008 09:56 AM
- Weekly Mergers and Acquisitions Report (Oct 29 - Nov 4)
Nov 04, 2008 06:26 PM
- A Bullish Outlook for Generic Drugs After Election
Nov 03, 2008 11:57 PM
- Virtual Funds: Healthcare Fund's Ranking/Performance In Q3 '08 And Overall
Nov 01, 2008 01:31 PM
- Weekly Mergers and Acquisitions Report
Oct 21, 2008 08:56 AM
- Barr Pharma Deal Should Close - Analyst Blog
Oct 13, 2008 04:53 PM
- Best Perfomers Over Last Quarter
Oct 06, 2008 02:19 AM
- Weekly Mergers and Acquisitions Report
Sep 24, 2008 05:32 PM
- FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream
Dec 01, 2008 09:06 AM
- Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg
Nov 26, 2008 12:21 PM
- Barr Shareholders Approve Pending Teva Acquisition
Nov 21, 2008 02:00 PM
- Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
Nov 19, 2008 08:02 AM
- Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges
Nov 19, 2008 01:30 AM
- Barr Reports Third Quarter 2008 GAAP Earnings of $0.28 Per Share; Adjusted Earnings of $0.83 Per Share
Nov 06, 2008 07:31 AM
- Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL
Nov 03, 2008 01:42 PM
- Teva and Barr Provide Update on Acquisition
Oct 27, 2008 05:31 PM
- Teva and Barr Provide Update on Acquisition
Oct 27, 2008 05:31 PM
- FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Oct 27, 2008 09:13 AM
- Form 4 GILMORE JAMES III For: Nov 25 (10K)
Nov 28, 2008 04:56 PM
- Form 4 DOWNEY BRUCE For: Nov 20 (10K)
Nov 24, 2008 09:36 PM
- Form 4 Wilkinson George Fred For: Nov 14 (10K)
Nov 17, 2008 04:47 PM
- Form 4 Sawyer Timothy For: Nov 14 (10K)
Nov 17, 2008 04:29 PM
- Form 4 BARR PHARMACEUTICALS For: Nov 14 Filed by: MUNDKUR CHRISTINE (10K)
Nov 17, 2008 04:18 PM
- Form 4 BARR PHARMACEUTICALS For: Nov 14 Filed by: Kirk Sigurd (10K)
Nov 17, 2008 04:00 PM
- Form 4 KILLION FREDERICK For: Nov 14 (10K)
Nov 17, 2008 03:55 PM
- Form 4 Greenman Jane F For: Nov 14 (10K)
Nov 17, 2008 03:42 PM
- Form 4 BARR PHARMACEUTICALS For: Nov 14 Filed by: DOWNEY BRUCE (10K)
Nov 17, 2008 03:35 PM
- Form 4 BOGDA MICHAEL For: Nov 14 (10K)
Nov 17, 2008 03:22 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
BRL
|
Compare to S&P
|
| YTD |
23.15 %
|
101.75 %
|
| 4 Weeks |
1.76 %
|
9.99 %
|
| 12 Weeks |
-3.30 %
|
34.04 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 29.69 %
|
|
EPS Growth in Last Year: 10.67 %
|
|
Sales Growth in Last Quarter: -5.39 %
|
|
Sales Growth in Last Quarter: 22.55 %
|
|
|
